Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice
FDA releases guidance with recommendations for drug manufacturers regarding good manufacturing practices and data integrity
